Orthopedic Surgery Doctors in Hannibal, MO Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

Dr. Curtis Dale Burton, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 188 Medical Dr, Hannibal, MO 63401 Phone: 573-248-1010    Fax: 573-248-0536

Dr. Christopher Michael Bieniek, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 188 Medical Dr, Hannibal, MO 63401 Phone: 573-248-1010    Fax: 573-248-0536

Dr. Richard Leo Baumann Jr., M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 188 Medical Dr, Hannibal, MO 63401 Phone: 573-248-1010    Fax: 573-248-0536

Gregory L. Henry, D.O. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6500 Hospital Drive, Hannibal, MO 63401 Phone: 573-629-3330    Fax: 573-629-3334

Rahul Basho, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 188 Medical Dr, Hannibal, MO 63401 Phone: 573-248-1010    Fax: 573-248-0536

News Archive

Study shows smoking presents significant risks to fracture patient

In a new study presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons, researchers reviewed existing literature on smoking and the healing of fractures involving long bones (bones that are longer than they are wide).

Pro-Pharmaceuticals reports net loss of $2.7 million for first quarter 2011

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the first quarter, ended March 31, 2011.

Johns Hopkins Bloomberg School of Public Health awarded $15 million for lab renovation

The Johns Hopkins Bloomberg School of Public Health will receive nearly $15 million from the American Recovery and Reinvestment Act (ARRA) for renovation and modernization of laboratory space at its main facility at 615 N. Wolfe Street in Baltimore, Md.

USF neuroscientists prove eye pressure is sufficient to cause and explain glaucoma

Neuroscientists at the University of South Florida have become the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

Zometa reduces bone loss in patients receiving breast cancer treatment

Data presented at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida, demonstrate that Zometa (zoledronic acid), an intravenous bisphosphonate, was shown to inhibit bone loss in postmenopausal women treated with Femara (letrozole) in the adjuvant breast cancer setting (directly following surgery to prevent cancer recurrence).

Read more Medical News

› Verified 7 days ago